Peter D Burbelo Selected Research

Luciferases

1/2020	Lethal Hemorrhagic Disease and Clinical Illness Associated with Elephant Endotheliotropic Herpesvirus 1 Are Caused by Primary Infection: Implications for the Detection of Diagnostic Proteins.
1/2020	Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
8/2019	Luciferase-Based Detection of Antibodies for the Diagnosis of HPV-Associated Head and Neck Squamous Cell Carcinoma.
12/2015	No Evidence of Antibodies against GAD65 and Other Specific Antigens in Children with Autism.
10/2015	Serological diagnosis of pulmonary Mycobacterium tuberculosis infection by LIPS using a multiple antigen mixture.
2/2015	Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases.
11/2013	The serological evidence in humans supports a negligible risk of zoonotic infection from porcine circovirus type 2.
1/2012	The Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma.
12/2010	Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia.
10/2010	Rapid induction of autoantibodies during ARDS and septic shock.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter D Burbelo Research Topics

Disease

32	Infections 09/2022 - 07/2008
14	COVID-19 09/2022 - 01/2020
13	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2010
6	Neoplasms (Cancer) 08/2019 - 08/2005
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 01/2012
5	Inflammation (Inflammations) 01/2021 - 10/2010
5	Opportunistic Infections (Opportunistic Infection) 01/2019 - 12/2010
4	Pneumonia (Pneumonitis) 01/2021 - 01/2019
4	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2013 - 05/2009
3	Human Influenza (Influenza) 12/2021 - 08/2009
3	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 01/2021 - 08/2016
3	Disease Progression 01/2021 - 09/2014
3	Communicable Diseases (Infectious Diseases) 10/2017 - 06/2010
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2015 - 09/2008
2	Virus Diseases (Viral Diseases) 12/2021 - 05/2016
2	Fever (Fevers) 07/2021 - 03/2021
2	Cough 07/2021 - 03/2021
2	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2020 - 01/2017
2	Viremia 01/2019 - 05/2012
2	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 10/2016
2	Persistent Infection 01/2018 - 02/2015
2	Kidney Diseases (Kidney Disease) 01/2017 - 07/2015
2	Myositis (Idiopathic Inflammatory Myopathies) 10/2016 - 03/2014
2	Epstein-Barr Virus Infections 04/2016 - 10/2011
2	Autistic Disorder (Autism) 12/2015 - 07/2013
2	Sjogren's Syndrome (Sjogren Syndrome) 09/2014 - 09/2009
2	Lyme Disease (Disease, Lyme) 09/2011 - 06/2010
2	Myasthenia Gravis 03/2011 - 12/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022
1	Cytokine Release Syndrome 09/2022
1	Hematologic Neoplasms (Hematological Malignancy) 09/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Gastritis 01/2022
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022
1	COVID-19 related pediatric multisystem inflammatory disease 01/2022
1	Reinfection 12/2021
1	Thymoma (Thymic Carcinoma) 11/2021
1	Encephalitis (Encephalitis, Rasmussen) 10/2021
1	type 1 Autoimmune polyendocrinopathy syndrome 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Proteinuria 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 08/2019
1	Colonic Neoplasms (Colon Cancer) 08/2019

Drug/Important Bio-Agent (IBA)

33	AutoantibodiesIBA 01/2022 - 02/2008
31	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2005
24	AntibodiesIBA 01/2022 - 08/2005
18	LuciferasesIBA 01/2020 - 02/2008
16	AntigensIBA 01/2022 - 07/2008
12	AutoantigensIBA 01/2022 - 09/2008
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2008
8	VaccinesIBA 12/2021 - 03/2009
5	CytokinesIBA 01/2021 - 12/2010
5	Antiviral Agents (Antivirals)IBA 12/2020 - 08/2009
5	DNA (Deoxyribonucleic Acid)IBA 05/2012 - 10/2009
4	InterferonsIBA 10/2020 - 08/2012
3	Neutralizing AntibodiesIBA 10/2021 - 10/2009
3	Immunoglobulin G (IgG)IBA 03/2021 - 07/2008
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021 - 07/2015
3	Nucleocapsid ProteinsIBA 01/2021 - 01/2020
3	Recombinant ProteinsIBA 01/2020 - 11/2013
3	Biological ProductsIBA 01/2018 - 06/2012
2	Insulin (Novolin)FDA Link 01/2022 - 01/2012
2	HLA-DR Antigens (HLA-DR)IBA 01/2022 - 01/2015
2	Adenosine Triphosphatases (ATPase)IBA 01/2022 - 03/2014
2	Oxygen (Dioxygen)IBA 07/2021 - 03/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2011
2	Phospholipase A2 ReceptorsIBA 01/2020 - 01/2017
2	EnzymesIBA 04/2016 - 02/2015
2	Glutamic Acid (Glutamate)FDA Link 12/2015 - 02/2008
2	Indicators and Reagents (Reagents)IBA 09/2015 - 05/2009
2	Viral RNAIBA 02/2015 - 10/2011
2	CyclinsIBA 05/2013 - 05/2009
2	EpitopesIBA 09/2011 - 03/2011
1	tisagenlecleucelIBA 09/2022
1	blinatumomabIBA 09/2022
1	Chimeric Antigen ReceptorsIBA 09/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	mRNA VaccinesIBA 11/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	bamlanivimab and etesevimab drug combinationIBA 01/2021
1	InterleukinsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Serum AlbuminIBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2019
1	NeodymiumIBA 08/2019
1	Oncogene Proteins (Oncogene Protein)IBA 08/2019
1	InflammasomesIBA 01/2019

Therapy/Procedure

6	Therapeutics 09/2022 - 11/2012
2	Critical Care (Surgical Intensive Care) 01/2021 - 10/2010
2	Immunomodulation 01/2019 - 12/2018
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Highly Active Antiretroviral Therapy (HAART) 01/2021
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2020
1	Immunotherapy 12/2020